Thyrocare Announces Newspaper Publication of Audited Financial Results for Q4FY26
Thyrocare Technologies Limited published its audited financial results for the quarter and year ended March 31, 2026, on May 9, 2026. The results are available in Navshakti and Business Standard, and on the company's website. The disclosure adheres to SEBI regulations.
This is a standard disclosure of financial results publication, which is a routine event for listed companies. It does not introduce new material information beyond the confirmation of the publication.
The announcement is a routine disclosure of financial results publication and does not contain any new financial information or outlook that would significantly impact the sentiment.
Thyrocare Technologies Limited has announced the publication of its audited financial results for the quarter and financial year ended March 31, 2026. The advertisements were published in the newspapers Navshakti (Marathi) and Business Standard (English) on May 9, 2026. The company has also provided a Quick Response (QR) code to access the full results, which are also available on the company's website, investor.thyrocare.com.
This disclosure is made pursuant to Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has informed the stock exchanges, NSE and BSE, about this publication. The detailed financial results can be accessed on the websites of the respective stock exchanges and the company.
The announcement also includes a table with financial data for the standalone and consolidated results for the quarter and year ended March 31, 2026, comparing it with previous periods. Key figures include total income from operations and net profit after tax.
What to do with a filing like this
Thyrocare Technologies Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Thyrocare Technologies Limited. Read the original for the full detail.